Folger Nolan Fleming Douglas Capital Management, Inc Laboratory Corp Of America Holdings Transaction History

Folger Nolan Fleming Douglas Capital Management, Inc

$915 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$209.01 - $232.56 $18,810 - $20,930	-90 Reduced 1.37%	6,466 $1.41 Million
Q3 2023 Oct 25, 2023	SELL	$201.05 - $221.7 $5,227 - $5,764	-26 Reduced 0.4%	6,556 $1.32 Million
Q2 2023 Jul 27, 2023	SELL	$211.93 - $241.33 $59,340 - $67,572	-280 Reduced 4.08%	6,582 $1.59 Million
Q1 2023 Apr 28, 2023	SELL	$213.32 - $257.83 $39,464 - $47,698	-185 Reduced 2.63%	6,862 $1.57 Million
Q4 2022 Jan 30, 2023	SELL	$203.72 - $248.97 $23,427 - $28,631	-115 Reduced 1.61%	7,047 $1.66 Million
Q3 2022 Nov 01, 2022	BUY	$204.81 - $262.19 $24,577 - $31,462	120 Added 1.7%	7,162 $1.47 Million
Q2 2022 Jul 15, 2022	BUY	$213.86 - $277.87 $22,455 - $29,176	105 Added 1.51%	7,042 $1.65 Million
Q1 2022 Apr 27, 2022	BUY	$259.82 - $298.18 $45,468 - $52,181	175 Added 2.59%	6,937 $1.83 Million
Q4 2021 Feb 01, 2022	SELL	$271.6 - $314.21 $100,492 - $116,257	-370 Reduced 5.19%	6,762 $2.13 Million
Q3 2021 Oct 29, 2021	BUY	$274.82 - $308.34 $49,467 - $55,501	180 Added 2.59%	7,132 $2.01 Million
Q2 2021 Aug 09, 2021	BUY	$251.87 - $278.14 $63,219 - $69,813	251 Added 3.75%	6,952 $1.92 Million
Q1 2021 May 11, 2021	BUY	$204.88 - $255.03 $49,171 - $61,207	240 Added 3.71%	6,701 $1.71 Million
Q4 2020 Feb 05, 2021	SELL	$186.91 - $214.42 $50,091 - $57,464	-268 Reduced 3.98%	6,461 $1.32 Million
Q3 2020 Nov 12, 2020	BUY	$167.03 - $201.3 $43,761 - $52,740	262 Added 4.05%	6,729 $1.27 Million
Q2 2020 Aug 05, 2020	BUY	$113.31 - $182.44 $22,662 - $36,488	200 Added 3.19%	6,467 $1.07 Million
Q1 2020 May 06, 2020	BUY	$104.32 - $195.28 $7,302 - $13,669	70 Added 1.13%	6,267 $792,000
Q4 2019 Feb 12, 2020	BUY	$163.48 - $173.61 $8,173 - $8,680	50 Added 0.81%	6,197 $1.05 Million
Q3 2019 Nov 08, 2019	BUY	$159.77 - $178.1 $67,902 - $75,692	425 Added 7.43%	6,147 $1.03 Million
Q2 2019 Aug 09, 2019	BUY	$144.16 - $172.9 $48,293 - $57,921	335 Added 6.22%	5,722 $989,000
Q1 2019 May 07, 2019	BUY	$123.7 - $156.3 $36,491 - $46,108	295 Added 5.79%	5,387 $824,000
Q4 2018 Feb 12, 2019	BUY	$120.82 - $174.09 $537,528 - $774,526	4,449 Added 691.91%	5,092 $643,000
Q4 2018 Feb 11, 2019	SELL	$120.82 - $174.09 $472,889 - $681,388	-3,914 Reduced 85.89%	643 $643,000
Q3 2018 Nov 07, 2018	BUY	$167.67 - $188.27 $261,565 - $293,701	1,560 Added 52.05%	4,557 $791,000
Q2 2018 Aug 08, 2018	BUY	$160.33 - $189.41 $75,355 - $89,022	470 Added 18.6%	2,997 $538,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,527	2,527 $389,000

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.

Account